Company Name: Anthera Pharmaceuticals, Inc.
Anthera Pharmaceuticals, Inc. is a biopharmaceutical company. The company’s product candidates include a pancreatic enzyme replacement therapy for those with exocrine pancreatic insufficiency (EPI) and a B-cell activating factor (BAFF) inhibitor designed to treat systemic lupus erythematosus and IgA nephropathy.
Ticker Symbol: ANTH (NASDAQ)
Company Website: www.anthera.com
Headquarters: Hayward‚ CA